Roxithromycin (Forilin, Surlid)
Eriksen, N.H.; Arpi, M.; Friis-Møller, A.
Ugeskrift for Laeger 152(6): 411-412
1990
ISSN/ISBN: 0041-5782 PMID: 2405561 Document Number: 360083
Document emailed within 1 workday
Related Documents
Zhang, S-qiu.; Zhang, L-feng.; Xing, J.; Zhong, D-fang. 2003: Metabolism of roxithromycin in dogs Yao Xue Xue Bao 38(5): 374-379Jehl, F.; Kolbe, R.; Chrétien, P.; Rosembaum, M.; Monteil, H. 1991: Diffusion of roxithromycin in gingival tissue Pathologie-Biologie 39(5): 511-514
Zhong, D.; Li, X.; Wang, A.; Xu, Y.; Wu, S. 2000: Identification of the metabolites of roxithromycin in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(5): 552-559
Shoji, S.; Watanabe, A.; Kikuchi, N.; Takahashi, Y.; Kikuchi, H.; Honda, Y.; Nukiwa, T. 1997: Effects of roxithromycin (RXM) on viruses and cultured cells Japanese Journal of Antibiotics 50 Suppl A: 140-141
Calvo, P.R.; Pérez, L.A. 1999: Asthma and infection: etiopathogenic factors and treatment with roxithromycin Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 12(1): 69-73
Shimane, T.; Asano, K.; Mizutani, T.; Hisamitsu, T.; Suzaki, H. 2000: Inhibitory action of roxithromycin on mast cell activation Japanese Journal of Antibiotics 53 Suppl A: 70-74
Lachat, J.M.; Anex, J.F.; Regamey, C. 1986: Roxithromycin (RU 28965), a new macrolide effective against pulmonary infections Schweizerische Medizinische Wochenschrift 116(49): 1739-1741
Labro, M.T.; Bryskier, A.; Babin-Chevaye, C.; Hakim, J. 1988: Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo Pathologie-Biologie 36(5 Part 2): 711-714
Horiuchi, Y.; Bae, S.; Katayama, I. 2006: Uncontrollable prurigo nodularis effectively treated by roxithromycin and tranilast Journal of Drugs in Dermatology: Jdd 5(4): 363-365
Seto, H.; Sasano, K.; Terao, H.; Suzaki, H. 2003: Suppressive effect of roxithromycin on NO production in fibroblasts of human nasal mucosa Japanese Journal of Antibiotics 56 Suppl A: 93-95
Bock, H.; Mares, A. 1997: Current status of Helicobacter pylori eradication therapy. Significance of roxithromycin Fortschritte der Medizin 115(27): 54-55
Radowicki, S.; Tyc, M.; Kulesza, E.; Dowgiałło-Smolarczyk, J. 1995: Roxithromycin (Rulid) in treatment of Chlamydia trachomatis genital infections in women Ginekologia Polska 66(6): 354-356
Rastogi, N.; Labrousse, V.; Bryskier, A. 1995: Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages Antimicrobial Agents and ChemoTherapy 39(4): 976-978
Morávek, J.; Matousovic, K.; Prát, V.; Sedivý, J. 1990: Pharmacokinetics of roxithromycin in kidney grafted patients under cyclosporin A or azathioprine immunosuppression and in healthy volunteers International Journal of Clinical Pharmacology Therapy and Toxicology 28(6): 262-267
Gasser, R.; Reisinger, E.; Sedaj, B.; Horvarth, R.; Seinost, G.; Keplinger, A.; Wendelin, I.; Klein, W. 1996: Oral treatment of late Lyme borreliosis with a combination of roxithromycin and co-trimoxazole--a pilot study on 18 patients Acta Medica Austriaca 23(3): 99-101
Okeke, E.N.; Juryit, Z.; Ikeh, E.I. 1995: Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections West African Journal of Medicine 14(4): 238-241
Leowattana, W.; Bhuripanyo, K.; Singhaviranon, L.; Akaniroj, S.; Mahanonda, N.; Samranthin, M.; Pokum, S. 2001: Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial Journal of the Medical Association of Thailand 84 Suppl. 3: S669-S675
Bertrand, A.; Jonquet, O.; Sauvaget, J. 1988: Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections Pathologie-Biologie 36(5): 544-547
Yamazaki, H.; Shimada, T. 1998: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1053-1057
Gross, R.; Mion, F.; Paliard, P. 1993: Cholestasis induced by roxithromycin in a patient with a past history of pregnancy intrahepatic cholestasis Gastroenterologie Clinique et Biologique 17(2): 146-147